financetom
Business
financetom
/
Business
/
L&T Finance Holdings Q2 Results | Net profit jumps 46% to Rs 595 crore, credit cost declines 10%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
L&T Finance Holdings Q2 Results | Net profit jumps 46% to Rs 595 crore, credit cost declines 10%
Oct 20, 2023 1:57 PM

L&T Finance Holdings Ltd, one of India’s leading non-banking financial companies, on Friday (October 20) reported a 46% year-on-year (YoY) jump in net profit at ₹595 crore for the second quarter that ended September 30, 2023.

In the corresponding quarter last year, L&T Finance Holdings posted a net profit of ₹406 crore, the company said in a regulatory filing.

In the quarter, total revenue stood at ₹3,169 crore during the period under review, up 2.7% against ₹3,086 crore in the corresponding period of the preceding fiscal.

The company's credit cost was down by 10% year-on-year at ₹517 crore in Q2 of FY24 compared to ₹575 crore in Q2 of FY23. It achieved the highest-ever quarterly retail disbursements at ₹13,499 crore, up 32% year-on-year compared to ₹10,238 crore in Q2 of FY23.

Also Read: Just Dial Q2 Results | Net profit rises 38% to ₹72 crore, revenue grows 27% to ₹261 crore

L&T Finance Holdings demonstrated a significant shift in its retail portfolio mix, which surged to 88% from 82% in the previous quarter and a substantial improvement from the 58% recorded in the same quarter the previous year.

This shift was accompanied by positive developments in retail asset quality, with Gross Stage 3 (GS3) at 3.05% and Net Stage 3 (NS3) at 0.67%. Moreover, the provision coverage ratio stood at a robust 79%.

The company's Retail Return on Assets (RoA) was notably impressive, registering at 3.32%, surpassing the set Lakshya FY26 target. Additionally, the Retail Return on Equity (RoE) achieved an encouraging 16.31%.

L&T Finance Holdings experienced substantial growth in its retail book size, marking a 33% year-on-year increase. In Q2 FY24, the retail book size reached ₹69,417 crore, compared to ₹52,040 crore in the same quarter of the previous fiscal year.

Also Read: Central Bank of India Q2 net profit zooms 90% to ₹605 crore on strong NII

The company has obtained NCLT approvals for the proposed merger of entities, a step closer to creating a single lending entity. The results came after the close of the market hours. Shares of L&T Finance Holdings Ltd ended at ₹137.80, down by ₹0.20, or 0.14 percent on the BSE.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Goldman Sachs sees more larger-scale strategic deals in 2025
Goldman Sachs sees more larger-scale strategic deals in 2025
Dec 10, 2024
NEW YORK(Reuters) - Goldman Sachs ( GS ) expects strategic deals by companies to accelerate in 2025 including large-scale mergers and acquisitions, its finance chief said on Tuesday. The intensity of our client dialog is accelerating and there are aspects of the overall strategic activity which are becoming more pronounced, Chief Financial Officer Dennis Coleman said at the Goldman Sachs...
Market Chatter: UBS Expands US Wealth Business to Serve More Than Just Super-Rich Clients
Market Chatter: UBS Expands US Wealth Business to Serve More Than Just Super-Rich Clients
Dec 10, 2024
11:28 AM EST, 12/10/2024 (MT Newswires) -- UBS Group ( UBS ) is restructuring its US wealth-management business to serve the affluent clients in addition to ultra-high net worth clients, the Wall Street Journal reported Tuesday, citing an email to staff. UBS did not immediately reply to a request for comment from MT Newswires. (Market Chatter news is derived from...
Incite Says Phase 3 Trial of Monjuvi in Follicular Lymphoma Patients Meets Endpoints
Incite Says Phase 3 Trial of Monjuvi in Follicular Lymphoma Patients Meets Endpoints
Dec 10, 2024
11:27 AM EST, 12/10/2024 (MT Newswires) -- Incyte ( INCY ) said Tuesday that late-breaking results from a phase 3 trial of tafasitamab, or Monjuvi, showed that it met a primary endpoint of progression-free survival, or PFS. The study evaluated tafasitamab in combination with lenalidomide and rituximab compared with placebo plus lenalidomide and rituximab in patients with relapsed or refractory...
DocGo Unit Renews Transport Contract With Tennessee Healthcare System
DocGo Unit Renews Transport Contract With Tennessee Healthcare System
Dec 10, 2024
11:27 AM EST, 12/10/2024 (MT Newswires) -- DocGo ( DCGO ) said Tuesday its Ambulnz unit has renewed its patient transport contract with a Tennessee healthcare system for two years, extending a six-year working relationship. Under the renewed deal, Ambulnz will keep providing hospital discharge transportation and interfacility transfers, the company said, adding Ambulnz also targets to exceed 20,000 trips...
Copyright 2023-2026 - www.financetom.com All Rights Reserved